Anaptysbio, Inc. · NASDAQ:ANAB

James N. Topper reported a 5.40% stake in Anaptysbio, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

James N. Topper reported a 5.40% stake in Anaptysbio, Inc., 1,655,295 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
5.40%
Shares
1,655,295
Intent
Passive
What changed
Stake changed
Filed together
25 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.2.00%
FHMLSP, L.P.2.00%612,503
FHMLSP, L.L.C.2.00%612,503
Frazier Life Sciences Public Overage Fund, L.P.0.30%77,778
FHMLSP Overage, L.P.0.30%77,778
FHMLSP Overage, L.L.C.0.30%77,778
Frazier Life Sciences X, L.P.0.30%77,014
FHMLS X, L.P.0.30%77,014
FHMLS X, L.L.C.0.30%77,014
Frazier Life Sciences XI, L.P.0.50%165,521
FHMLS XI, L.P.0.50%165,521
FHMLS XI, L.L.C.0.50%165,521
Frazier Healthcare VII, L.P.1.60%498,769
Frazier Healthcare VII-A, L.P.0.50%142,134
FHM VII, L.P.2.10%640,903
FHM VII, L.L.C.2.10%640,903
James N. Topper5.40%1,655,295
Patrick J. Heron5.20%1,583,593
Albert Cha2.30%690,281
James Brush2.30%690,281
Daniel Estes0.50%165,521
Alan Frazier2.10%640,903
Nader Naini2.10%640,903
Nathan Every2.10%645,526
Brian Morfitt2.10%646,272

Source

View original at SEC

Related